Twelve-week oral administration of BPS improved insulin sensitivity without altering body weight, BMI, waist circumference or lipid profile in human patients with type 2 diabetes (209), suggesting PGI2 supplementation improves insulin sensitivity without improving AT function. This evidence concerns the gene INS and type 2 diabetes mellitus.